Molecular Movie Captures Cancer Cells Rewriting DNA Instructions to Escape Targeted Therapy Within Days

ISB researchers discover that melanoma cells use epigenetic shifts to escape drugs within days, revealing a new target for preventing cancer drug resistance.

By: AXL Media

Published: Apr 18, 2026, 4:54 AM EDT

Source: Information for this report was sourced from Institute for Systems Biology

Therapeutic Stress Acts as an Unintended Survival Signal

Groundbreaking research from the Institute for Systems Biology (ISB) has revealed that cancer drugs designed to eradicate tumors may inadvertently trigger an early escape mechanism. While medical science has traditionally viewed drug resistance as a late-stage development driven by new genetic mutations, this study indicates that the process begins within hours of the first dose. By exposing melanoma cells to BRAF-targeted therapies, researchers observed that the cells do not passively wait for mutations to emerge. Instead, the initial shock of treatment induces a rapid stress response that drives a fraction of the tumor population into a temporary, drug-tolerant state. According to Wei Wei, PhD, co-senior author of the study, cancer cells actively reprogram their internal biology to survive the immediate impact of the medicine.

Mapping the Sequential Waves of Genetic Reprogramming

To capture this elusive transition, the ISB team utilized high-resolution, time-series multi-omics to create what they describe as a "molecular movie" of the cancer’s adaptation. The study, published in Nature Communications, found that this identity shift is not a random drift but an ordered sequence of events. The transformation unfolds through two distinct "transcriptional waves" that systematically reorganize gene activity and cellular function. During these waves, melanoma cells move away from their specialized, drug-sensitive identity and adopt a more primitive, resilient state. This coordinated survival program allows the cells to endure the therapeutic onslaught, providing a critical window of time for permanent resistance to eventually take hold.

The NF-κB Trigger and Chromatin Architecture

At the heart of this adaptive mechanism is a molecular sentinel known as NF-κB, which traditionally regulates cellular stress and immune responses. Targeted therapies disrupt the antioxidant defenses within cancer cells, leading to a surge in reactive oxygen species (ROS), commonly known as oxidative stress. This surge activates NF-κB, which then recruits epigenetic enzymes to physically remodel chromatin, the packaging system for DNA. By locking away specific genetic instructions and opening others, the cell effectively rewrites its operational manual. A primary target of this remodeling is the SOX10 transcription facto...